References
- Cardenas A, Sordillo JE, Rifas-Shiman SL, et al. The nasal methylome as a biomarker of asthma and airway inflammation in children. Nat Commun. 2019; 10(1):3095. doi:https://doi.org/10.1038/s41467-019-11058-3.
- Deckers J, Branco Madeira F, Hammad H. Innate immune cells in asthma. Trends Immunol. 2013; 34(11):540–547. doi:https://doi.org/10.1016/j.it.2013.08.004.
- Ichikawa T, Panariti A, Audusseau S, et al. Effect of bronchial thermoplasty on structural changes and inflammatory mediators in the airways of subjects with severe asthma. Respir Med. 2019; 150:165–172. doi:https://doi.org/10.1016/j.rmed.2019.03.005.
- Pua HH, Ansel KM. MicroRNA regulation of allergic inflammation and asthma. Curr Opin Immunol. 2015; 36:101–108. doi:https://doi.org/10.1016/j.coi.2015.07.006.
- Singh PB, Pua HH, Happ HC, et al. MicroRNA regulation of type 2 innate lymphoid cell homeostasis and function in allergic inflammation. J Exp Med. 2017; 214(12):3627–3643. doi:https://doi.org/10.1084/jem.20170545.
- Mattes J, Collison A, Plank M, et al. Antagonism of microRNA-126 suppresses the effector function of TH2 cells and the development of allergic airways disease. Proc Natl Acad Sci U S A. 2009; 106(44):18704–18709. doi:https://doi.org/10.1073/pnas.0905063106.
- Collison A, Mattes J, Plank M, et al. Inhibition of house dust mite-induced allergic airways disease by antagonism of microRNA-145 is comparable to glucocorticoid treatment. J Allergy Clin Immunol. 2011; 128(1):160–167 e4. doi:https://doi.org/10.1016/j.jaci.2011.04.005.
- Zhang H, Sun Z, Yu L, et al. MiR-139-5p inhibits proliferation and promoted apoptosis of human airway smooth muscle cells by downregulating the Brg1 gene. Respir Physiol Neurobiol. 2017; 246:9–16. doi:https://doi.org/10.1016/j.resp.2017.07.004.
- Kv A, Madhana RM, Js IC, et al. Antidepressant activity of vorinostat is associated with amelioration of oxidative stress and inflammation in a corticosterone-induced chronic stress model in mice. Behav Brain Res. 2018; 344:73–84. doi:https://doi.org/10.1016/j.bbr.2018.02.009.
- Loh C-Y, Arya A, Naema AF, et al. Signal Transducer and Activator of Transcription (STATs) Proteins in Cancer and Inflammation: Functions and Therapeutic Implication. Front Oncol. 2019; 9:48 doi:https://doi.org/10.3389/fonc.2019.00048.
- Liu C, et al. Inhibition of JAK-STAT Signaling with Baricitinib Reduces Inflammation and Improves Cellular Homeostasis in Progeria Cells. Cells. 2019; 8(10):1276–1295. doi:https://doi.org/10.3390/cells8101276.
- Zhang J, Zhu Y, Wang R. Long noncoding RNAs in respiratory diseases. Histol Histopathol. 2018; 33(8):747–756.
- Austin PJ, Tsitsiou E, Boardman C, et al. Transcriptional profiling identifies the long noncoding RNA plasmacytoma variant translocation (PVT1) as a novel regulator of the asthmatic phenotype in human airway smooth muscle. J Allergy Clin Immunol. 2017; 139(3):780–789. doi:https://doi.org/10.1016/j.jaci.2016.06.014.
- Lin J, et al. Long noncoding RNA TUG1 promotes airway smooth muscle cells proliferation and migration via sponging miR-590-5p/FGF1 in asthma. Am J Transl Res. 2019; 11(5):3159–3166.
- Qiu Y-Y, Wu Y, Lin M-J, et al. LncRNA-MEG3 functions as a competing endogenous RNA to regulate Treg/Th17 balance in patients with asthma by targeting microRNA-17/ RORγt. Biomed Pharmacother. 2019; 111:386–394. doi:https://doi.org/10.1016/j.biopha.2018.12.080.
- Li X, Wang X, Song W, et al. Oncogenic Properties of NEAT1 in Prostate Cancer Cells Depend on the CDC5L-AGRN Transcriptional Regulation Circuit. Cancer Res. 2018; 78(15):4138–4149. doi:https://doi.org/10.1158/0008-5472.CAN-18-0688.
- Shui X, Chen S, Lin J, et al. Knockdown of lncRNA NEAT1 inhibits Th17/CD4(+) T cell differentiation through reducing the STAT3 protein level. J Cell Physiol. 2019;234(12):22477–22484., doi:https://doi.org/10.1002/jcp.28811.
- Fang L, et al. IgE Downregulates PTEN through MicroRNA-21-5p and Stimulates Airway Smooth Muscle Cell Remodeling. Int J Mol Sci. 2019; 20(4):875–894
- Lin T-Y, Venkatesan N, Nishioka M, et al. Monocyte-derived fibrocytes induce an inflammatory phenotype in airway smooth muscle cells. Clin Exp Allergy. 2014; 44(11):1347–1360. doi:https://doi.org/10.1111/cea.12421.
- Wei XY. [Down-regulation of expression of alpha- smooth muscle actin in airway smooth muscle cells by allicin and its mechanisms]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2013; 25(3):164–166.
- Yao J, Jiang M, Zhang Y, et al. Chrysin alleviates allergic inflammation and airway remodeling in a murine model of chronic asthma. Int Immunopharmacol. 2016; 32:24–31. doi:https://doi.org/10.1016/j.intimp.2016.01.005.
- Eguiluz-Gracia I, et al. Monocytes accumulate in the airways of children with fatal asthma. Clin Exp Allergy. 2018; 48(12):1631–1639.
- Ross KR, et al. Severe asthma during childhood and adolescence: A longitudinal study. J Allergy Clin Immunol. 2020; 145(1):140–146.e9.
- Du M, Yuan L, Tan X, et al. The LPS-inducible lncRNA Mirt2 is a negative regulator of inflammation. Nat Commun. 2017; 8(1):2049 doi:https://doi.org/10.1038/s41467-017-02229-1.
- Zhang X-Y, Zhang L-X, Tian C-J, et al. LncRNAs BCYRN1 promoted the proliferation and migration of rat airway smooth muscle cells in asthma via upregulating the expression of transient receptor potential 1. Am J Transl Res. 2016; 8(8):3409–3418.
- Zhu Y, Mao D, Gao W, et al. Analysis of lncRNA Expression in Patients With Eosinophilic and Neutrophilic Asthma Focusing on LNC_000127. Front Genet. 2019; 10:141 doi:https://doi.org/10.3389/fgene.2019.00141.
- Keenan CR, Schuliga MJ, Stewart AG. Pro-inflammatory mediators increase levels of the noncoding RNA GAS5 in airway smooth muscle and epithelial cells. Can J Physiol Pharmacol. 2015; 93(3):203–206. doi:https://doi.org/10.1139/cjpp-2014-0391.
- Zhang F, Wu L, Qian J, et al. Identification of the long noncoding RNA NEAT1 as a novel inflammatory regulator acting through MAPK pathway in human lupus. J Autoimmun. 2016; 75:96–104. doi:https://doi.org/10.1016/j.jaut.2016.07.012.
- Hartmann P, Zhou Z, Natarelli L, et al. Endothelial Dicer promotes atherosclerosis and vascular inflammation by miRNA-103-mediated suppression of KLF4. Nat Commun. 2016; 7:10521 doi:https://doi.org/10.1038/ncomms10521.
- Iliopoulos D, Hirsch HA, Struhl K. An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell. 2009; 139(4):693–706. doi:https://doi.org/10.1016/j.cell.2009.10.014.
- Zhao MZ, et al. Expression level of micrna-126 in serum exosomes of allergic asthma patients and lung tissues of asthmatic mice. Curr Drug Metab. 2019;20(10):799–803.
- Tu J, Zhao Z, Xu M, et al. NEAT1 upregulates TGF-β1 to induce hepatocellular carcinoma progression by sponging hsa-mir-139-5p. J Cell Physiol. 2018; 233(11):8578–8587. doi:https://doi.org/10.1002/jcp.26524.
- Zou F, Mao R, Yang L, et al. Targeted deletion of miR-139-5p activates MAPK, NF-κB and STAT3 signaling and promotes intestinal inflammation and colorectal cancer. Febs J. 2016; 283(8):1438–1452. doi:https://doi.org/10.1111/febs.13678.
- Katsumi T, Ninomiya M, Nishina T, et al. MiR-139-5p is associated with inflammatory regulation through c-FOS suppression, and contributes to the progression of primary biliary cholangitis. Lab Invest. 2016; 96(11):1165–1177. doi:https://doi.org/10.1038/labinvest.2016.95.
- Li RF, Wang GF. JAK/STAT5 signaling pathway inhibitor ruxolitinib reduces airway inflammation of neutrophilic asthma in mice model. Eur Rev Med Pharmacol Sci. 2018; 22(3):835–843.
- Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer. 2009; 9(11):798–809. doi:https://doi.org/10.1038/nrc2734.
- O'Shea JJ, Pesu M, Borie DC, et al. A new modality for immunosuppression: targeting the JAK/STAT pathway. Nat Rev Drug Discov. 2004; 3(7):555–564. doi:https://doi.org/10.1038/nrd1441.
- Laurence A, Tato CM, Davidson TS, et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity. 2007; 26(3):371–381. doi:https://doi.org/10.1016/j.immuni.2007.02.009.